View Grant Opportunity

FY 2026 DRUG COURT TRAINING AND TECHNICAL ASSISTANCE COMPETITIVE COOPERATIVE AGREEMENT SOLICITATION

Office of National Drug Control Policy

DCT-DCT-26-001

ONDCP

General Information

$6,000,000
Est. Program Funding:
August 27, 2026
Closing Date:
1
Expected No. of Awards
$6,000,000
Award Ceiling

Opportunity Number:
DCT-DCT-26-001

Owning Agency:
ONDCP

Opportunity Category:
Discretionary (D)

Synopsis

ONDCP’s Drug Court Training and Technical Assistance Cooperative Agreement supports training and technical assistance (TTA) to ensure access to evidence-based addiction treatment through drug courts, including when substance use disorder co-occurs with other mental healthconditions. ONDCP seeks to reduce drug use and its consequences through evidence-based treatment that leads to long-term recovery, and this cooperative agreement will support the President’s priorities by applying this to the criminal justice system. The purpose of this cooperative agreement is to: (1) educate, train, and produce materials to improve the implementation of evidence-based treatment to individuals with addiction, including when substance use disorder co-occurs with other mental health conditions; (2)decrease criminal justice costs and recidivism rates; and (3) improve access to evidence-based addiction treatment that includes medications for opioid use disorder through drug courts. The cooperative agreement recipient shall:• Use expert practitioners in the science of addiction and evidence-based addiction treatment, as well as integration of treatment into the criminal justice system.• Use licensed behavioral health practitioners.• Provide in-person training, online training, and jurisdiction-specific technical assistanceto a wide range of geographically distributed areas—including rural locations—at thestate, local, and tribal levels.• Ensure close alignment of all TTA materials with the Trump Administration’s policy priorities, including the 2026 National Drug Control Strategy; an evidence-based approach to treating addiction--to include FDA-approved medications for opioid use disorder--contingency management, and other evidence-based behavioral health modalities for other substance use disorders; naloxone distribution and naloxone training.• Designate and fund a research or academic organization to conduct an independent assessment of the effectiveness and impact of training and technical assistance conducted under this cooperative agreement. The independent study should involve data collectionfrom state, local, and tribal jurisdictions engaged in cooperative agreement recipient programming.

Response Date Aug 27, 2026 12:00:00 AM EDT
Posting Date Jul 15, 2026 12:00:00 AM EDT
Archive Date Sep 26, 2026 12:00:00 AM EDT
Award Ceiling 6,000,000
Award Floor 6,000,000
Cost Sharing No

Eligibility

Eligible Applicants Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Info on Eligibility: N/a

Additional Information

Agency Name Michele C Marx Grantor
Link to Additional Information: GrantSolutions
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact: GrantSolutions Help Desk
Phone: 202-395-6883

CFDA Program(s)

  • 95.005: Drug Court Training and Technical Assistance
   

Contact Us



Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.

×

Request Grant Support from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.